Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dyax wins third phage-display patent:

This article was originally published in Clinica

Executive Summary

Technology that allows scientists to identify and capture molecules with important characteristics from a mixture containing millions of compounds won a third US patent last week. Desirable molecular properties include high specificity and high affinity, and are important for diagnostics and separation technology. Dyax has already signed licensing agreements with a number of companies interested in its so-called phage display technology, and plans further deals following its newest patent.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel